Список литературы

1. Серов В.Н. и др. Руководство по амбулаторно-поликлинической помощи в акушерстве и гинекологии//М.: ГЭОТАР-Медиа. - 2016., ГЭОТАР-Мед. Москва.

2. Апгар Б.С., Броцман Г.Л., Шпицер М. Клиническая кольпоскопия. Практическое руководство//М.: Практическая медицина. - 2014. - Т. 384., Практическ. Москва.

3. Роговская С.И., Липова Е.В. Шейка матки, влагалище, вульва//Физиология, патология, кольпоскопия, эстетическая коррекция: Руководство для практикующих врачей. - 2014.

4. Сайт "Международная ассоциация по патологии шейки матки и кольпоскопии". URL: www IFCPC info/com.

5. Bruno MT, Cassaro N, Bica F, Boemi S. Progression of CIN1/LSIL HPV Persistent of the Cervix: Actual Progression or CIN3 Coexistence. Infect Dis Obstet Gynecol. 2021 Mar 9; 2021: 6627531.

6. Global Cancer Observatory: World. (2022). Accessed: February 15, 2024: https://gco.iarc.who.int/media/globocan/factsheets/populations/900-world-fact-sheet.pdf.

7. Massad L Stewart, Perkins Rebecca B et al. Colposcopy Standards: Guidelines for Endocervical Curettage at Colposcopy. J Low Genit Tract Dis. 2023 Jan 1; 27(1): 97 - 101.

8. The International Agency for Research on Cancer (IARC) of the World Health Organization, Atlas of visual inspection of the cervix with acetic acid for screening, triage, and assessment for treatment 2023.

9. Nayar R., Wilbur D.C. The Bethesda System for reporting cervical cytology: a historical perspective//Acta cytologica. - 2017. - Т. 61. - N 4 - 5. - С. 359 - 372.

10. Bouvard V et al. WHO International Agency for Research on Cancer Monograph Working Group. A review of human carcinogens-Part B: biological agents. Lancet Oncol. 2009 Apr; 10(4): 321 - 2.

11. Короленкова Л.И., Ермилова В.Д. Зона трансформации шейки матки как объект канцерогенного действия вирусов папилломы человека при возникновении цервикальных интраэпителиальных неоплазий и инвазивного рака//Архив патологии. - 2011. - Т. 73. - N 6. - С.

12. Короленкова Л.И. Цервикальные интраэпителиальные неоплазии и ранние формы рака шейки матки: клинико-морфологическая концепция цервикального канцерогенеза. - 2017. Москва.

13. Kohale M.G., Dhobale A.V., Hatgoankar K., et al. Comparison of Colposcopy and Histopathology in Abnormal Cervix. (February 15, 2024) Cureus 16(2): e54274.

14. Состояние онкологической помощи населению России в 2022 году. Под ред. Каприна, А.Д., Старинского, В.В., Петровой, Г.В. МНИОИ им. П.А. Герцена филиал ФГБУ "НМИЦ радиологии" Минздрава России. 2023.

15. Sanad A.S., Kamel H.H., Hasan M.M. Prevalence of cervical intraepithelial neoplasia (CIN) in patients attending Minia Maternity University Hospital//Archives of gynecology and obstetrics. - 2014. - Т. 289. - N 6. - С. 1211 - 1217.

16. Benard V.B. et al. Population-based incidence rates of cervical intraepithelial neoplasia in the human papillomavirus vaccine era//JAMA oncology. - 2017. - Т. 3. - N 6. - С. 833 - 837.

17. Shahida S.M. et al. Prevalence of Cervical Intraepithelial Neoplasia in four Upazila of Dhaka Division//Mymensingh medical journal: MMJ. - 2019. - Т. 28. - N 3. - С. 655.

18. Y.R. Kurman RJ, Carcangiu ML, Herrington CS, WHO Classification of Tumours of Female Reproductive Organs. 2014.

19. Fontham E.T.H. et al. Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society//CA: a cancer journal for clinicians. - 2020.

20. Richart RM. Natural history of cervical intraepithelial neoplasia. Clin Obstet Gynecol. 1967; 10: 748.

21. Comprehensive Cervical Cancer Control: A Guide to Essential Practice. 2nd ed. Geneva: World Health Organization; 2014.

22. Roura E et al. The Influence of Hormonal Factors on the Risk of Developing Cervical Cancer and Pre-Cancer: Results from the EPIC Cohort. PLoS One. 2016.

23. Li XY et al. Non-Genetic Factors and Risk of Cervical Cancer: An Umbrella Review of Systematic Reviews and Meta-Analyses of Observational Studies. Int J Public Health. 2023.

24. Unim B. et al. Role of pap-test in cervical cancer prevention: a systematic review and meta-analysis Brigid Unim//European Journal of Public Health. - 2014. - Т. 24. - N suppl_2.

25. Шабалова И.П., Касоян К.Т. Цитология жидкостная и традиционная при заболеваниях шейки матки//Цитологический атлас. - 2016.

26. Koliopoulos G. et al. Cytology versus HPV testing for cervical cancer screening in the general population//Cochrane Database of Systematic Reviews. - 2017. - N 8.

27. Савельева Г.М. и др. Национальное руководство//Акушерство - М.: Гэотар-Медиа. - 2015.

28. Nayar R., Wilbur D.C. The pap test and Bethesda 2014//Acta cytologica. - 2015. - Т. 59. - N 2. - С. 121 - 132.

29. Каприн А.Д. и др. Скрининг рака шейки матки - нерешенные проблемы//Research'n Practical Medicine Journal. - 2015. - Т. 2. - N 1.

30. Сухих Г.Т. и др. Профилактика рака шейки матки. - 2012.

31. Honarvar Z et al. Comparison of conventional and liquid-based Pap smear methods in the diagnosis of precancerous cervical lesions. J Obstet Gynaecol. 2022 Aug; 42(6): 2320 - 2324.

32. Artymuk N.V., Marochko K.V. Predictive value of different diagnostic methods for detection of cervical intraepithelial neoplasia and cervical cancer//Lietuvos ir ginekologija. - 2017. - Т. 20. - N 3. - С. 222 - 227.

33. European Commission European Health Union: New Approach on Cancer Screening. Available online: https://ec.europa.eu/commission/presscorner/detail/en/ip_22_7548.

34. Jeronimo J. et al. Secondary prevention of cervical cancer: ASCO resource-stratified clinical practice guideline. J Glob Oncol. 2017; 3 (5): 635 - 57.

35. Белокриницкая Т.Е. и др. Результативность и приемлемость обследования на вирус папилломы человека при самостоятельном и врачебном заборе вагинального отделяемого//Акушерство и гинекология. - 2017. - N 2. - С. 97 - 105.

36. Артымук Н.В., Марочко К.В. Эффективность выявления вируса папилломы человека при помощи устройства для самостоятельного забора вагинального отделяемого//Акушерство и гинекология. - 2016. - N 3. - С. 85 - 91.

37. Arbyn M, Smith Sara B, Temin Sarah et al. Detecting cervical precancer and reaching underscreened women by using HPV testing on self samples: updated meta-analyses. BMJ. 2018.

38. Gennaro GD et al. Does self-sampling for human papilloma virus testing have the potential to increase cervical cancer screening? An updated meta-analysis of observational studies and randomized clinical trials. Front Public Health. 2022.

39. WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention, second edition. World Health Organization 2021.

40. Royal College of Obstetricians and Gynaecologists: "Progress in Cervical Screening in the UK" Scientific Impact Paper No. 7.

41. Khan M.J., Cervical Cancer Screening: Evolution of National Guidelines and Current Recommendations. Clin Obstet Gynecol. 2023 Sep 1; 66(3): 470 - 477, vol. 127, no. 1. 2016.

42. FIGO guidance for sustainable implementation of vaccination programs for women: Pregnancy and HPV 2023 https://doi.org/10.1002/ijgo.14894. 2009.

43. Bonde J.H. et al. Clinical Utility of Human Papillomavirus Genotyping in Cervical Cancer Screening: A Systematic Review//Journal of lower genital tract disease. - 2020. - Т. 24. - N 1. - С. 1 - 13.

44. Katki H.A. et al. Five-year risk of CIN3+ and cervical cancer for women with HPV-positive and HPV-negative high-grade Pap results//Journal of lower genital tract disease. - 2013. - Т. 17. - N 5 0 1. - С. S50.

45. Rampuria S, Chandwaskar N: Comparative study of PAP smear and colposcopy with cervical biopsy. Int J Reprod Contracept Obstet Gynecol. 2023, 12:2113-18.10.18203/2320-1770.ijrcog20231919.

46. Goksedef BP, Api M, Kaya O et al. Diagnostic accuracy of two endocervical sampling method: randomized controlled trial. Arch Gynecol Obstet. 2013 Jan; 287(1): 117 - 22.

47. Shafi M. I. European quality standards for the treatment of cervical intraepithelial neoplasia (CIN). European Federation for Colposcopy. - 2007.

48. Se Ik Kim et al. Pathologic discrepancies between colposcopy-directed biopsy and loop electrosurgical excision procedure of the uterine cervix in women with cytologic high-grade squamous intraepithelial lesions. Gynecol Oncol. 2020.

49. Perkins Rebecca B.et al. 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors. J Low Genit Tract Dis. 2020.

50. Feldman S., Crum C. P, Cervical cancer screening tests: Techniques for cervical cytology and human papillomavirus testing. Up Today version Jul. 2024.

51. Yu L.L. et al. Evaluation of p16/Ki-67 dual staining in detection of cervical precancer and cancers: a multicenter study in China//Oncotarget. - 2016. - Т. 7. - N 16. - С. 21181.

52. Peeters E. et al. Meta-analysis of the accuracy of p16 or p16/Ki-67 immunocytochemistry versus HPV testing for the detection of CIN2+/CIN3+ in triage of women with minor abnormal cytology//Cancer cytopathology. - 2019. - Т. 127. - N 3. - С. 169 - 180.

53. Зароченцева Н.В., Белая Ю.М. Заболевания шейки матки у молодых женщин. Вопросы практической кольпоскопии. Генитальные инфекции. 2023.

54. Yu Ma et al. Comparison of the detection rate of cervical lesion with TruScreen, LBC test and HPV test: A Real-world study based on population screening of cervical cancer in rural areas of China. PLoS One. 2020.

55. Yingting Wei et al. Clinical evaluation of a real-time optoelectronic device in cervical cancer screening. Eur J Obstet Gynecol Reprod Biol. 2021.

56. World Health Organization et al. WHO guidelines for screening and treatment of precancerous lesions for cervical cancer prevention. 2023//Geneva. WHO. - 2023.

57. COTARCEA S. et al. The Importance of Ultrasound Monitoring of the Normal and Lesional Cervical Ectropion Treatment//Current health sciences journal. - 2016. - Т. 42. - N 2. - С. 188.

58. Del Priore G. et al. Oral diindolylmethane (DIM): pilot evaluation of a nonsurgical treatment for cervical dysplasia//Gynecologic oncology. - 2010. - Т. 116. - N 3. - С. 464 - 467.

59. Castanon A. et al. Effect of diindolylmethane supplementation on low-grade cervical cytological abnormalities: double-blind, randomised, controlled trial//British journal of cancer. - 2012. - Т. 106. - N 1. - С. 45.

60. Белокриницкая Т.Е. и др. Проспективная оценка эффективности лечения цервикальных энтраэпителиальных неоплазий, ассоциированных с папилломавирусной инфекцией//Акушерство и гинекология. - 2016. - N 4. - С. 86 - 93.

61. Сухих Г.Т. и др. Исследование эффективности и безопасности препарата на основе дииндолметана у пациенток с цервикальной интраэпителиальной неоплазией (CIN 1 - 2).//Акушерство и гинекология. - 2018. N 9.

62. Ashrafian L. et al. Double-blind randomized placebo-controlled multicenter clinical trial (phase IIa) on diindolylmethane's efficacy and safety in the treatment of CIN: implications for cervical cancer prevention//EPMA Journal. - 2015. - Т. 6. - N 1. -.

63. Mantoani PTS, Jammal MP, Caixeta JM, et al. Association of lesion area measured by colposcopy and cervical neoplasia. J Obstet Gynaecol. 2022; 42(2) 306 - 9.

64. Elit L. et al. Expectant management versus immediate treatment for low-grade cervical intraepithelial neoplasia: a randomized trial in Canada and Brazil//Cancer. - 2011.

65. NHS. Cervical Screening Programme. http://www.cancerscreening.nhs.uk/cervical/publications/reviews-leaflets.html.

66. P.P. Martin-Hirsch, Ed., Lei, L., Zhang, L., Zheng, Y. et al. Clinical analysis of 314 patients with high-grade squamous intraepithelial lesion who underwent total hysterectomy directly: a multi-center, retrospective cohort study. BMC Cancer 24, 575 (2024). John Wiley & Sons, Ltd.

67. van der Heijden E. et al. Follow-up strategies after treatment (large loop excision of the transformation zone (LLETZ)) for cervical intraepithelial neoplasia (CIN): Impact of human papillomavirus (HPV) test//Cochrane Database of Systematic Reviews.

68. Tanaka Y. et al. Predictors for recurrent/persistent high-grade intraepithelial lesions and cervical stenosis after therapeutic conization: a retrospective analysis of 522 cases//International journal of clinical oncology. - 2017. - Т. 22. - N 5. - С. 9.

69. Kew F. M., Cruickshank D. J. Routine follow-up after treatment for a gynecological cancer: a survey of practice//International Journal of Gynecologic Cancer. - 2006. - Т. 16. - N 1. - С. 380 - 384.

70. Минкина Г.Н. и др. Постлечебный мониторинг цервикальных интраэпителиальных неоплазий//Журнал акушерства и женских болезней. - 2011. - Т. 60. - N 1.

71. Meijer C. et al. Validation of high-risk HPV tests for primary cervical screening//Journal of Clinical Virology. - 2009. - Т. 46. - С. S1 - S4.

72. Poljak M et al. Commercially available molecular tests for human papillomaviruses: a global overview. Clin Microbiol Infect. 2020.

73. Vaccines against human papillomavirus infection: WHO position paper. Strategic Advisory Group of Experts (SAGE) on Immunization. Document and Report to SAGE March 2022, no. 43. 2014.

74. Баранов А.А. и др. Вакцинопрофилактика заболеваний, вызванных вирусом папилломы человека: позиции доказательной медицины. Обзор клинических рекомендаций//Вопросы современной педиатрии. - 2017. - Т. 16. - N 2.

75. Jura EA, Kirgiu M, Bosch Forex, et al. Human papillomavirus vaccination: ESGO-European Society EFC Position Paper of Gynecological Oncology and that of the European Federation for colposcopy. Euro J Cancer. 2019.

76. Marta del Pino, Alex Vorsters A., Joura E., et.al., Risk factors for human papillomavirus infection and disease: A targeted literature summary. Medical virology. 2024, vol. 129, no. 6. 2017.

77. Report of the Meeting of the WHO Global Advisory Committee on Vaccine Safety, 15 - 16 May 2023 ttps://www.who.int/publications/i/item/who-wer9832-345-354.

78. Вакцины против папилломавирусной инфекции человека: документ по позиции ВОЗ., http://www.who.int/wer, N 19, 2017.

79. Kjaer S et al. A 12-year follow-up on the long-term effectiveness of the quadrivalent human papillomavirus vaccine in 4 Nordic countries. Clinical Infectious Diseases. 2018; 66(3): 339 - 345.

80. Naud P.S. et al. Sustained efficacy, immunogenicity, and safety of the HPV-16/18 AS04-adjuvanted vaccine: final analysis of a long-term follow-up study up to 9.4 years post-vaccination//Human vaccines & immunotherapeutics. - 2014. - Т. 10. - N 8. - С.

81. Sharpless Kathryn E et al. ASCCP Committee Opinion: Adjuvant Human Papillomavirus Vaccine for Patients Undergoing Treatment for Cervical Intraepithelial Neoplasia. J Low Genit Tract Dis. 2023.

82. Cao D, Wu D, Xu Y. Vaginal intraepithelial neoplasia in patients after total hysterectomy. Curr Probl Cancer. 2021.